Skip to content
  • News
  • Compare
  • Capital
variis
  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Events
  • Funds
  • Press
variis

Longevity intelligence for Singapore and Australia. Sourced and evidence-graded.

Directories

  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Funds
  • Events

Read

  • Archive
  • Capital
  • Compare
  • Glossary

Markets

  • Singapore
  • Australia

variis

  • About
  • Editorial standards
  • AI transparency
  • Corrections
  • Press

Legal

  • Medical disclaimer
  • Privacy policy
  • Terms of service

AI-assisted reporting, human-reviewed. Every claim sourced and graded. Not medical advice.

© 2026 variis · Singapore · Australia

  1. Home
  2. Companies
  3. Mesoblast

Company

Mesoblast

ASX:MSB / NASDAQ:MESO

First FDA-approved MSC product (Ryoncil).

At a glance

Listing
ASX:MSB / NASDAQ:MESO
Category
ASX listed
Headquarters
Melbourne
Market cap
~A$2.6–2.8B

Thesis

Why it is in this universe

Category
ASX listed
Market
Australia
Recent inflection
Apr 2026 FDA IND clearance for Ryoncil in Duchenne MD; Ryoncil Y1 revenue ~US$100M.
Services
None recorded
People tracked
None on file

Market data

Listing and scale

MetricDetail
ExchangeASX
TickerASX:MSB / NASDAQ:MESO
Secondary listingNASDAQ
Market cap~A$2.6–2.8B
StatusListed and trading
Editor's noteA listing or financing event is not a clinical result. variis grades evidence on the linked protocol, not the share price.

Get in touch

Contact

Address
Melbourne
Website
No site on file
Phone
No public number published
Email
No public address published

Offering

What it sells today

No commercial services are recorded for this company yet.

Recent inflection

What moved lately

Apr 2026 FDA IND clearance for Ryoncil in Duchenne MD; Ryoncil Y1 revenue ~US$100M.

Common questions

Why does variis track Mesoblast?
First FDA-approved MSC product (Ryoncil).
Is Mesoblast publicly listed?
Yes. It trades as ASX:ASX:MSB / NASDAQ:MESO. Market capitalisation is in the ~A$2.6–2.8B range, recorded as a dated snapshot rather than a live quote.
Where is Mesoblast based?
Melbourne
Is Mesoblast still trading?
Mesoblast is recorded as actively trading.

Keep reading

Related coverage from the newsroom.

Singapore and Australia · Capital

Singapore and Australia · Capital

Two rounds, one IPO: how Singapore and Australia are funding longevity in 2025 to 2026

Suggest an update

Sources

What this profile is built on

No source is on file for this company yet. Treat everything above as unverified until one is.

Last updated 14 August 2026

Every entity profile on variis is sourced. Not investment advice.